Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Ask whether your plan distinguishes between weight loss coverage and coverage for other GLP-1 indications like cardiovascular risk reduction or sleep apnea
Additional metabolic investigations, including fasting glucose, HbA1c, and lipid profiles, can help assess overall metabolic health
The severity of these symptoms is mainly mild to moderate, and they are most prominent at treatment initiation and intensification (44)
Important considerations for ongoing treatment: Regular review with the prescribing healthcare professional is essential Treatment should be discontinued if no clear benefit is observed after an adequate trial period (typically 812 weeks) Do not delay seeking medical attention for new or worsening symptoms Be alert to red flag symptoms requiring urgent assessment, such as unexplained weight loss, persistent fever, chest pain, or suicidal thoughts Patients should maintain realistic expectations , recognising that robust evidence for clinical benefits remains limited
US$ 20.41
US$ 28.30
US$ 29.69
US$ 21.05
US$ 23.77
